Latest Whitepapers

This whitepaper explores how AAV titration and anti-AAV antibody ELISA kits streamline AAV-based gene therapy research, enhancing patient stratification, optimizing preclinical studies and supporting regulatory compliance.

This interview explores expert insights into cutting-edge methodologies that overcome these challenges, providing actionable insights to optimize vaccine safety and efficacy.

This whitepaper explores innovative approaches to achieving higher yields and stability, ensuring a seamless transition from lab to large-scale manufacturing.

This article explores how mRNA and VLP vaccines represent a significant advancement in vaccine technology and will play a role in protection against infectious diseases.

This whitepaper explores how artificial intelligence (AI), machine learning (ML) and deep learning (DL) are transforming cellular imaging and drug discovery, enabling researchers to analyze complex datasets with unprecedented speed and accuracy.

This whitepaper explores innovative chromatography techniques to enhance aggregate removal and improve overall mAb recovery, ensuring higher quality and more effective therapeutic solutions.

This whitepaper outlines the external factors influencing balance performance and how they play a crucial part in choosing a balance for the highest-quality results.

In this article, we take a look at how researchers are tackling some of the challenges that are preventing cell therapies from being more widely used, paying particular attention to cellular immunotherapies for cancer and induced pluripotent stem cel

This whitepaper evaluates the results of a study into the three main capping options available to manufacturers, highlighting expert insights on mRNA capping costs and customer needs.

Scientists are constantly innovating newer technologies that allow them to understand nuances within these drugs and find ways to manufacture them more reliably.